Predict your next investment

Entopsis company logo
HEALTHCARE | Biotechnology

See what CB Insights has to offer

Founded Year



Unattributed | Alive

Total Raised


Last Raised

$1.04M | 5 mos ago

About Entopsis

Entopsis is a privately held company developing novel biomedical products for research and clinical use, predominantly in the areas of oncology, autoimmune disorders, metabolic disorders and developing world malignancies. The company has established various strategic industry and academic research collaborations geared towards advancing company goals.

Entopsis Headquarter Location

7600 NW 69th Ave

Miami, Florida, 33166,

United States


Latest Entopsis News

Madison Core Laboratories : Initiates New Innovation Effort to Better Serve Clients

Aug 13, 2020

0 Message :   Madison Core Laboratories (“MCL”) announced today the launch of a company-wide initiative to become the most innovative diagnostic testing company in the region and provide unsurpassed testing services to better serve clients. This press release features multimedia. View the full release here: The on-going COVID-19 pandemic has called attention to numerous inefficiencies and problems plaguing the diagnostic industry. There are solutions on the market that can address many of these problems. Many testing laboratories do not incorporate innovative solutions due to a lack of time, will or ability to adequately utilize these new tools. MCL is tackling testing for one of the hardest hit industries and patients in the nation: The Elderly population and Long-Term Care (LTC) facilities. We are the preferred and, in some cases, the only mobile phlebotomy and laboratory provider for a large segment of the LTC market in the South East. Madison Core Laboratories will take a proactive approach to innovation and stand apart from alternative testing laboratories. Our goal will be to identify inefficiencies and validate appropriate solutions in-house with our highly qualified team. We will continue to emphasize innovation as a core company principle. A prime example of our commitment to innovation is the utilization of alternatives to nucleic acid extraction. Such extractions, particularly viral RNA extraction for COVID-19 testing, are currently a multi-step, time-consuming and expensive process. Madison Core Laboratories has identified and validated Entopsis’ PCRopsisTM Reagent RVD as an innovative solution to this problem. Other impactful technologies offered by Entopsis and similar companies are currently being evaluated. “I’m looking to transform MCL to an innovative industry leader. We are committed to offering clients unparalleled, accurate testing options in a timely fashion. To do so, we will utilize all tools at our disposal,” said Carlo Crespo , M.D., CEO of Madison Core Laboratories. “The Entopsis team’s mission is to develop impactful solutions to problems often considered intractable and then align ourselves with visionary industry leaders. MCL is such a partner,” said Obdulio Piloto , Ph.D., CEO of Entopsis. “We have a suite of technologies that will offer laboratories meaningful alternatives to outdated processes in the diagnostic industry,” said Francis Lim, Ph.D., Senior Scientist at Entopsis. Madison Core Laboratories expects to complete the initial phase of its innovation project in the next six months. About Madison Core Laboratories: Madison Core Laboratories is one of the leading independent laboratories in Alabama. We provide extensive laboratory services using state-of-the art testing equipment to provide our clients with the latest innovations in the laboratory spectrum. Our clients include physician offices, long-term care facilities, assisted living facilities, homebound patients, and industrial/corporate testing needs. MCL is the only independent reference laboratory in the State of Alabama that offers mobile phlebotomy, molecular diagnostics, routine blood, urine, and toxicology testing all under one organization. Learn more at . Follow us on Facebook and LinkedIn . About Entopsis: Entopsis was founded to pursue the simple idea that an unbiased approach to diagnostics offers unique clinical and scientific insights. The company has two main platforms: (1) OpsisDx TM: nanotech platform powered by artificial intelligence to simultaneously diagnose multiple diseases through urine and (2) PCRopsis TM: series of novel research tools that optimize research procedures. The company is developing a suite of innovative solutions to combat the COVID-19 pandemic that facilitate all aspects of testing on a global scale. Entopsis is backed by Peter Thiel’s Breakout Labs . View source version on © Business Wire 2020

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Entopsis

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Entopsis is included in 5 Expert Collections, including Artificial Intelligence ( AI ) in Healthcare.


Artificial Intelligence ( AI ) in Healthcare

826 items

These healthcare startups are using AI to discover new drugs, remotely monitor patients, securely transfer patient data, and more.


Artificial Intelligence

7,340 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.



5,731 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.



4,844 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.


Digital Health

9,302 items

Companies that use or incorporate digital technology into their health/wellness product & service offerings. Only those that have raised funding after 01/01/2010

Entopsis Patents

Entopsis has filed 1 patent.

The 3 most popular patent topics include:

  • Biotechnology
  • Blood
  • Blood tests
patents chart

Application Date

Grant Date


Related Topics



Molecular biology, Blood tests, Transfusion medicine, Blood, Biotechnology


Application Date


Grant Date


Related Topics

Molecular biology, Blood tests, Transfusion medicine, Blood, Biotechnology



Entopsis Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Entopsis Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.